1. Short title This Act may be cited as the Essential Medicines Strategic Stockpile Act of 2023 . 2. Pilot program on ensuring medication supply stability Part D of title III of the Public Health Service Act ( 42 U.S.C. 254b et seq. ) is amended by adding at the end the following new subpart: XIII Ensuring Medication Supply Stability 340J. Ensuring medication supply stability (a) Award of contracts Beginning not later than January 1, 2024, the Secretary shall award contracts to eligible entities to each implement and test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile that— (1) consists of generic drugs at risk of shortage; and (2) is of sufficient quantity to ensure that customers in the United States have access to such drugs for at least 6 months (as specified by the Secretary based on the historic demand for those drugs). (b) Selection of drugs (1) In general The Secretary shall— (A) select not more than 50 drugs that may be included by eligible entities in a stockpile pursuant to a contract under this section; (B) maintain an up-to-date list of such drugs; and (C) make such list publicly available. (2) Choice of eligible entities A contract awarded to an eligible entity under this section need not require the stockpile of the eligible entity to include all 50 drugs listed pursuant to paragraph (1). (c) Sufficient quantity For each generic drug listed pursuant to subsection (b)(1), the Secretary shall specify the quantity of such drug that is sufficient to ensure that consumers in the United States have access to such drug for at least 6 months. (d) Duration